Regional risk of tuberculosis and viral hepatitis with tumor necrosis factor-alpha inhibitor treatment: A systematic review

N Jahnich, PD Arkwright - Frontiers in Pharmacology, 2023 - frontiersin.org
Background: TNFα inhibitors are regularly used to treat autoimmune diseases. Tuberculosis
(TB) and viral hepatitis B are considered potential infectious complications, and screening …

Association of tumor necrosis factor inhibitors with the risk of nontuberculous mycobacterial infection in patients with rheumatoid arthritis: a nationwide cohort study

HJ Park, B Choi, YK Song, YJ Oh, EB Lee… - Journal of Clinical …, 2023 - mdpi.com
Tumor necrosis factor inhibitors (TNFi) are proposed as a risk factor for nontuberculous
mycobacteria (NTM) infection. Limited research investigates NTM infection risk in …

Clinical characteristics of rheumatoid arthritis patients complicated with pulmonary nontuberculous mycobacterial disease: A cross-sectional case series study

Y Nakayama, E Tanaka, M Ueyama… - Modern …, 2023 - academic.oup.com
Objectives Pulmonary nontuberculous mycobacterial disease (pNTM) is a common
pulmonary complication of rheumatoid arthritis (RA), but their association has rarely been …

[PDF][PDF] Nonhealing Ulcer in a Patient With Crohn Disease

B Javdan, S Marwaha, M Ali, C Wassef - Cutis, 2023 - cdn.mdedge.com
A 24-year-old man presented to our dermatology clinic with a painful lesion on the right
buccal cheek of 4 months' duration that had not changed in size or appearance. He had a …

Nontuberculous Mycobacterial Pulmonary Disease in the immunocompromised host

CD Varley, AC Streifel, AM Bair… - Clinics in Chest …, 2023 - chestmed.theclinics.com
Nontuberculous Mycobacterial Pulmonary Disease in the Immunocompromised Host - Clinics
in Chest Medicine Skip to Main Content Skip to Main Menu Advertisement Clinics in Chest …